Phillip Andrew Dennis insider trades

Open-market stock purchases and sales by Phillip Andrew Dennis, Chief Medical Officer at NovaBridge Biosciences, from SEC Form 4 filings since Jun 17, 2026.

Recent trades

DateStockTradeValue
Sep 18, 2026NBP NovaBridge BiosciencesSold$5.8K
Sep 17, 2026NBP NovaBridge BiosciencesBought (not open market)—
Sep 17, 2026NBP NovaBridge BiosciencesBought (not open market)—
Jun 18, 2026NBP NovaBridge BiosciencesSold$5.6K
Jun 17, 2026NBP NovaBridge BiosciencesBought (not open market)—
Jun 17, 2026NBP NovaBridge BiosciencesBought (not open market)—

Companies traded

  • NBP NovaBridge Biosciences: 2 sales, last Sep 18, 2026

Get free alerts when Phillip Andrew Dennis files a new trade →